CORRESP 1 filename1.htm nby20200827_corresp.htm

 

 

 August 28, 2020

 

 VIA EDGAR

 

 Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, DC 20549
   

Re:

 NovaBay Pharmaceuticals, Inc. (the “Company”)

 Form S-3, File No. 333-248238
   
   Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective as of 5:00 p.m. (Eastern time) on Tuesday, September 1, 2020, or as soon as practicable thereafter.

 

 

   

Very truly yours,
       
   

NovaBay Pharmaceuticals, Inc.
       
       
   

By:

 /s/ Justin Hall 
     

Justin Hall
     

Chief Executive Officer and General Counsel
       
       

cc:

Abby E. Brown, Squire Patton Boggs (US) LLP